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To determine an early indicator of immunological disturbance in SILs, the role of serum-soluble interleukin (IL)-2 receptor (sIL-2R) was analyzed. Often SILs, immunological clinical parameters such as immunoglobulin (Ig) G, complements, the titer of autoantibodies including anti-nuclear antibodies (ANA), anti-ScI-70 antibody (Ab) and anti-centromere (CM) Ab, and experimental indicators such as serum-soluble Fas, serum IL-2, CD25+ cells in CD4+ or CD8+ fractions, and sIL-2R were divided from respiratory parameters such as % vital capacity (%VC), percentage of forced expiratory volume in 1 second (FEVl.O%) and v25/Ht (liter/second/m(body height) by a correlation assay. Additionally, a stepwise regression test showed that sIL-2R was correlated with Ig G, ANA and anti-CM Ab. Furthermore, factor analysis revealed that sIL-2R contributed to the subpopulation of SILs with poorer immunological status in the absence of alterations in respiratory status. By defining healthy donors as 1, SILs as 2 and patients with systemic sclerosis as 3 for immunopathological progression status as metric variables, sIL2R and ANA showed a strong positive correlation. This suggests that sIL-2R is a good clinical indicator of immunological disturbance found in SILs without clinical manifestations of any disturbance in autoimmunity. Further analysis using a large-scale number of patients should be performed to confirm these findings.
Silicosis patients (SILs) develop respiratory disorders, manifested as pulmonary fibrosis and typical granular nodules in lung fields, with impaired pulmonary function (l). Silica is regarded as one of the strongest environmental substances which can lead to the impairment of autoimmunity (2) (3) . For instance, Caplan syndrome is common in SILs with rheumatoid arthritis (4) . Systemic sclerosis (SSe) is also known to be induced by environmental substances such as vinyl chloride and organic solvents, as well as silica (5) (6) . Moreover, these immunological disturbances have been found not only in SILs exposed to natural crystalline silica (SiO z)' but also in patients who received plastic surgery with implants containing silicone ([SiO z-0-]n) (7) . These epidemiological findings clearly indicate that crystalline silica causes deregulation and/or disturbances of the human immune system, particularly autoimmunity.
We previously reported on the cellular and molecular changes associated with Fas and Fasrelated molecules in SILs and healthy donors (HD) (8) (9) (10) . Fas is considered to be critical for apoptotic events in immunocompetent cells, such as T cells, and the impairment of Fas through mutation results in excessive autoreaction which causes lymphoproliferative lymphoadenopathy and the occurrence of autoimmune disorders due to the unexpected long-term survival of self-recognizing T cell clones (11).
Conditions associated with the expression of abnormal Fas or Fas-related molecules include (i) elevated levels of serum-soluble Fas (sFas) in SILs, (ii) excessive expression of soluble rather than wildtype Fas genes in peripheral blood mononuclear cells (PBMCs) from SILs, (iii) excessive detection of variant messages of Fas transcripts as well as sFas, (iv) excessive expression of decoy receptor 3 (DcR3) in PBMCs from SILs, (v) reduced expression of intracellular anti-apoptotic molecules related to Fas-mediated apoptosis in PBMCs from SILs, and (vi) the detection of functional (apoptosis inducible) serum anti-Fas autoantibody in SILs (8) (9) (10) (12) (13) (14) (15) (16) . These Fas-related parameters were isolated as immunological parameters from other respiratory clinical parameters such as percent vital capacity (%VC), profusion rate (PR), which is a category pertaining to radiological findings according to the International Labor Office (ILO) guideline (17) , and the percentage of forced expiratory volume in 1 second (FEVl.O%) (18) .
The high-affinity interleukin-2 receptor (IL-2R) is a multichain receptor which possesses at least three IL-2 binding chains: IL-2Ra (55 kDa), which binds the monoclonal antibody anti-Tac, IL-2R~(75 kDa) and 11-2Ry (64 kDa). IL-2Ra is also present as a naturally occurring soluble molecule (sIL-2R) (19) (20) (21) (22) (23) . Markedly elevated serum sIL-2R levels have been reported as a characteristic feature of certain hematologic malignancies such as human T lymphotropic retrovirus type I-associated adult T-cell leukemia and hairy cell leukemia, reflecting tumor burden and response to therapy. Furthermore, recent studies have indicated that a rise in serum sIL-2R levels in apparently healthy individuals could be an important early signal of neoplastic, autoimmune or inflammatory disease (19) (20) (21) (22) (23) .
The aim ofthis study is to determine whether slL-2R could be used as an indicator for the detection of immunological alterations present in SILs.
MATERIALS AND METHODS

Subjects and clinical parameters
All subjects were Japanese. Ten HDs [age (mean ± standard deviation (SD)) = 60.6 ± 5.8, male:female = 6:4], ten SILs (age = 74.4 ± 8.7, M:F=7:3) and ten SSc (age = 50.8 ± 13.3, M:F=2:8) patients were the subjects of this study. All SILs were brickyard workers in Bizen City, Okayama Prefecture, Japan, and were monitored at Kusaka Hospital. The amount of free silica inhaled by these patients was estimated to be as high as 40 to 60% as determined from their work environment. The subjects were diagnosed with pneumoconiosis according to the ILO 2000 guideline. They showed no clinical symptoms of autoimmune diseases such as sclerotic skin, Raynaud's phenomenon, facial erythema and arthralgia. The SSc patients were monitored at the Department ofDermatology, Kawasaki Medical School Hospital, Japan. Half of the SSc patients were administered oral corticosteroids. Heparinized peripheral blood was drawn from the cubital vein from all subjects. Samples from SILs were subjected to analyses examining the positive ratio ofCD25+ cells in CD4+ cells or CD8+ cells using flow cytometry following staining with specific monoclonal antibody as previously reported (8, 24) . Serum samples from all subjects were analyzed for (i) anti-nuclear antibodies (ANA) using the Enzyme-Linked ImmunoSorbent Assay (ELISA)-based MESACUP ANA TEST (MBL Co. Ltd., Nagoya, Japan), (ii) serum immunoglobulin (Ig) G concentration, (ii), titer of Anti-ScI-70 antibody (Ab) using an ELISA-based kit (MBL), (iv) titer of anti-centromere (CM) Ab using an ELISA kit (MBL), and (v) sIL-2R using an ELISA kit (MBL). The ANA titer performed in this study included several recombinant proteins such as RNP, SS-A/Ro, SS-B/La, ScI-70, Jo-I and Ribosomal P in vitro transcribed UI RNA and CENP-B protein, and purified antigens (Sm, SS-AlRo, ScI-70m Histone and DNA). All measurements were performed according to the manufacturer's instructions and ANA, anti-Scl-70 and anti-CM Abs were presented as index values. The clinical data [exposure years, FEVI.O%, %VC, body height corrected v25/H (Lls/m), PR (numbered according to the ILO guideline, 1 to 4) and subjective dyspnea (numbered as 1: slight, 2: mild, 3: moderate and 4: severe, according to the Hugh-Jones classification)] were provided by Kusaka Hospital. All specimens were taken after informed consent had been obtained. This study was approved by the Ethics Committees of Kawasaki Medical School and Kusaka Hospital.
Statistical analysis
Clinical parameters including research-based ANA, anti-Scl-70, anti-centromere, and sIL-2R values are presented in Table 1 . For the SILs, correlations of all respiratory and immunological parameters with age were initially analyzed. Following this, a stepwise regression test was performed to assess how each parameter was defined by other parameters, and whether the speculated respiratory and immunological factors were independently defined. Factor analysis was performed to identify parameters associated with sIL-2R among the SIL clinical parameters. For the factor analysis, parameters showing a factor loading value greater than ±OA were defined as meaningful to configure the factors.
To ascertain whether the immunological parameters (ANA, Ig G, anti-Scl-70 Ab, anti-CM Ab and sIL-2R) were related to the progression of altered autoimmunity, differences between HDs, SILs and SSc were analyzed for each parameter. To define HDs =1, SILs = 2 and SSc =3 as metric variables for immunological progression, the correlation between these numbers and each parameter value were analyzed. All statistical analyses were performed using StatView software version 5.0 (SAS Institute Inc. Cary, NC, USA) and StatFlex version 5.0 software for Windows (Artech Co. Ltd., Osaka, Japan), which yield results that are compatible with the SPSS software.
RESULTS
Correlations among clinical parameters in SILs
In this study, SILs without any clinical manifestations of autoimmune diseases were analyzed. The aim of this study is to determine whether (i) silica causes subclinical alterations of immunological functions in all SILs, (ii) individual immunological parameters similarly reflect the immunological alterations found in SILs, and (iii) sIL-2R, a relatively new parameter for the detection of autoimmune abnormalities, can be used to detect subsequent clinical manifestations of autoimmune diseases such as SSc in SILs.
For these purpose, the clinical parameters shown in Table I were selected. Initially, all correlations between these parameters were analyzed and are shown in Table II . Regarding age, it was reasonably apparent that %VC and v25/Ht showed negative correlation, and that IL-2 concentrations showed positive correlations. FEVl.O% and v25/Ht showed negative correlation with symptomatic dyspnea (the higher number of dyspnea reflecting a poorer respiration status), and v25/Ht also showed positive correlations with FEVl.O% and %VC. Thus, respiratory parameters showed an inverse correlation. For the immunological parameters, Ig G was positively correlated to sIL-2R, the titers of ANA, anti-Scl-70 Ab and anti-CM Ab, even though most of the patients monitored displayed normal values of these parameters. The percentage of CD8+25+/ CD8+ cells showed a negative correlation with anti-Scl-70 Ab and FEVl.O%, and although the precise role of CD8+25+ cells in human diseases remains unknown, this finding should be kept in mind for further analysis. IL-2 was negatively correlated with %VC and v25/Ht. For these findings, age may have played a factor, as mentioned above. Although there is the possibility that activation ofimmune responses revealed by elevated IL-2 contributes to the formation and development of silicotic pulmonary fibrosis, serum IL-2 concentrations may result from the progression of lung fibrosis caused by silica.
Stepwise regression test in SILs
It should be noted that although this study included only a relatively small number of SILs, the results obtained, which were statistically significant, should be taken into account when considering the care of SILs in terms of respiratory and immunological disturbances.
A stepwise regression test was performed to confirm the results obtained by the correlation assay and to determine which parameters are closely related to other parameters. As shown in Table III , among the 10 SILs examined, FEVl.O% could be accounted for by v25/ht. v25/Ht showed a correlation with FEVl.O% and %VC. The immunological parameters showed no discernible correlation with the respiratory parameters. On the other hand, Ig G showed correlation with slL-2R. Additionally, sIL-2R showed correlation with ANA and anti-CM Ab. From this analysis, it was determined that the respiratory parameters showed no correlation with the immunological parameters in terms of the pathophysiology of SILs. Furthermore, it was determined that sIL-2R is very important among the various immunological parameters exam ined, since it showed corre lation with several other imm unological parameters.
Factor analysis in SILs
Factor analysis was performed in an effort to identify clinical parameters related to the other parameters. Parameters showing factor loading values greater than ±OAwere defined as meaningful for factor configuration and are shaded in gray (Table IV) . Therefore, the data can be interpreted in terms of (i) the parameters that have an influence, (ii) how parameter values reflect the degree of influence (whether the loading value is negative or positive, and where a value near 1.0 shows strong influence), and (iii) the contribution ratio.
According to the analysis shown in Table IV On the other hand, Factor 2 showed a greater To defin e the relati onship between clinical parameters, a stepwise regression test was perf orm ed using each parameter as an objective variable in an effort to identify parameters as exp lanatory variables. The high er t values with p <.05 indicate significant explanatory variables. p <.05 was extracted and listed and t>3.0 are shaded in gray. RC: regress ion coefficient; @CMAb: anti-centrom ere antib ody ; @Scl 70Ab: anti-ScI-70 antibody; sIL-2 R: soluble interleuk in-Z receptor. influence of Ig G, soluble Fas, CD4+25+ cell population, sIL-2R and centromere-Ab, and a relatively weak positive relation to FEVl.O%. Except for the CD4+25+ cell population, all of the other immunological parameters extracted in Factor 2 suggest poorer clinical manifestations. The contribution ratio of Factor 2 was 26%. Thus, 26% of patients showed poorer immunological status in the absence of any alterations in respiratory status. Finally, Factor 3 is of interest since it was associated with negative PR and dyspnea values and with higher soluble Fas and ANA titer. Factor 3 suggests that 14.5% of patients revealed no pulmonary progression, but specified alterations of immunological findings in SILs.
Immunological parameters among HDs, SILs and SSc
From the analyses using clinical parameters among SILs, as shown in Tables I to IV, sIL-2R is considered to be the most critical immunological parameter in SILs since it was correlated to Ig G, ANA and anti-CM Ab, and was the strongest parameter in the Factor 2 analysis which reflected immunological progression in the absence of respiratory alterations. Thus, sIL-2R in addition to ANA, Ig G, anti-Scl-70 Ab and anti-CM Ab were identified as immunological parameters which can be utilized to predict the subsequent progression of autoimmunity in SILs. HDs were collected as the negative control. SSc samples were utilized for the positive control since silica is the most important environmental factor in terms of the development of SSc. Additionally, the correlation_~etween disease activity and serum sIL-2R concentrations in SSc has been well documented (25) (26) (27) (28) .
To compare the immunological makers (Ig G, ANA titer, anti-Scl-70 Ab titer, anti-CM Ab titer and sIL-2R), all the data were expressed as logarithms and compared to clarify the influence of disease status (HDs, SILs and SSc). The statistical differences between each group (HDs, SILs and SSc) were analyzed. Additionally, by defining HDs =1, SILs = 2 and SSc =3 as metric variables for immunological progression, the correlation between these numbers, immunopathological progression status and each parameter value were analyzed.
As shown in Fig. 1 , the ANA titer between HDs and SILs, HDs and SSc, Ig G between HDs and SSc, the anti-CM Ab titer between HDs and SSc, and sIL-2R between HDs and SSc revealed significant differences, with SSc being higher than SILs and HDs, and SILs higher than HDs. Additionally, Ig G was higher in SILs than in HDs, the anti-Scl-70 Ab titer was higher in SSc than in SILs and HDs, the anti-CM Ab titer was higher in SSc than in SILs, and sIL2R was higher in SILs than in HDs.
Since these results indicated that autoimmunity disturbances increased in the order HDs < SILs < SSc, the diseased status was numbered using HDs as 1, SILs as 2, and SSc as 3 when examining the correlations with immunological parameters. As a result, the ANA titer, Ig G, anti-Scl-70 Ab titer, anti-CM Ab titer and sIL-2R showed significant correlation with correlation coefficients of .749, .378, .394, .464 and .575, respectively, and low p values (p <.0001, p=.0424, p=.0337, p=.0104 and p=.0008, respectively).
These results indicated that SILs were ranked between HDs and SSc in terms of immunopathological progression. Furthermore, sIL-2R, the ANA titer and Ig G are useful indicators for the early detection of immunological disturbance in SILs.
Case report
A 78 year-old male was recently admitted in our hospital. He worked as a tiler handling Japanese tiles (called Kawara in Japanese) for 20 years and was diagnosed as having silicosis. In October of 2008, he suffered from sclerotic skin and Raynaud's phenomenon which were then diagnosed as SSc given the higher titer of anti-Scl-70 Ab (>500 index value). In this case the serum sIL-2R level was 1,340 Ulml, being two-fold higher than the upper limit of normal values.
DISCUSSION
SILs are defined by respiratory disorders caused by inhaled silica-dust and are characterized by progressive impairment due to respiratory fibrosis and pulmonary function disorders (1) . The condition is regarded as a typical autoimmune disorder caused by environmental substances (2) (3) . Silica is known to cause autoimmune diseases such as rheumatoid arthritis (known as Caplan syndrome) (4), SSc and SLE (5) (6) . Our studies have focused on investigating alterations in Fas and Fas-related molecules since the impairment of Fas (through mutagenesis) can lead to autoimmune diseases (11) . Our previous study showed that the CD4+25+Treg fraction derived from SILs possess impaired regulatory function (24) . This reduction in the Treg fraction may be involved in the genesis of autoimmune disturbance found in SILs (8) (9) (10) .
Markedly elevated serum sIL-2R levels have been reported as being characteristic of certain hematologic malignancies, such as adult T-cell leukemia and hairy cell leukemia, reflecting tumor burden and response to therapy (19) (20) (21) (22) (23) . Additionally, recent studies have indicated that a rise in serum sIL-2R levels in apparently healthy individuals could be an important early signal of neoplastic, autoimmune or inflammatory disease (19) (20) (21) (22) (23) . Furthermore, a positive correlation between disease activity and serum sIL-2R levels has been reported since early 1990. sIL-2R is produced by proteolytic cleavage on activated T cell membranes. The most important biological role of sIL-2R is considered to be related to its similar affinity to IL-2 and membrane-bound IL-2R. Therefore, sIL-2R may interfere with the binding between membrane-bound IL-2R and IL-2 (25) . This may induce additional production of IL-2 from antigen-presenting cells such as dendritic cells, and may cause prolonged effector T cell activation. On the other hand, activated T cells are known to produce membrane-bound and a soluble form of IL-2R. Thus, serum sIL-2R concentrations may reflect the activation status of T cells. Taken together, these data show sIL-2R plays a role in the activity of autoimmune diseases and T cell activation against tumor cells. With respect to SSc, few reports have detailed a relationship between serum sIL-2R levels and fibroblastic activity (30) (31) . Therefore, the possibility arises that sIL-2R reflects the progression of fibrosis in SILs whereas, as mentioned below, sIL-2R showed no correlation to any of the respiratory parameters in SILs. Thus, sIL-2R can be utilized as an indicator for immunological alterations in SILs.
Statistical analyses performed in this study showed that sIL-2R can be utilized as a sensitive clinical indicator to detect early subclinical alterations in autoimmune status caused by silica exposure since sIL-2R is strongly correlated with Ig G and ANA. Additionally, sIL-2R is the strongest contributor to Factor 2, as determined by factor analysis, which reflected immunological alterations in SILs in the absence of deteriorating respiratory status. Moreover, a comparison of serum sIL-2R concentrations among HDs, SILs and SSc showed that sIL-2R in addition to the ANA titer were sensitive factors indicating immunopathological progression from HDs to SSc, with SILs being located between both groups.
As we reported previously, SILs showed elevated soluble Fas levels compared with HDs, with the levels being similar in patients with systemic lupus erythematosus (SLE) (12) . However, soluble Fas ligand levels were not elevated in SILs, and were higher in SLE (13) . Although soluble Fas is known to be produced by alternative splicing of Fas transcript, soluble Fas ligand is secreted following proteolytic cleavage of membrane-bound Fas ligand. Taken together with the findings on this study, it is not considered that silica causes excess activity of proteolytic reactions on the T cell membrane. Therefore, further investigations are required to delineate the mechanisms involved in the overproduction of sIL-2R from T cells caused by silica exposure. Furthermore, it will be necessary to measure sIL-2R levels in SILs or people exposed to silica and who show no signs of pulmonary fibrosis to confirm the clinical usefulness of sIL-2R in SILs.
Although this study was confined to a limited number of collected case samples, being dependent on administrative circumstances and available cases, several interesting findings were demonstrated and suggestions for future investigations have been established. The case was also documented of a patient who was diagnosed with SSc, complicated with silicosis, which showed a higher value of sIL-2R. These analyses may. be useful in furthering our understanding of the pathophysiology of autoimmune diseases in relation to SILs at the preautoimmune stage. on asbestos-related diseases), KAKENHI grants (18390186, 19659153 and 20390178) and Kawasaki Medical School Project Grants (18-601, 19-603T, 20-4101 and 20-603).
